TrialStroke2015

Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis.

Opeolu Adeoye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.